- Abstract
- Core Tip
- Article Highlights
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (22)
- Timeline of Article Publication (2)
- Authors Evaluation (1)
- Article Quality Tracking (0)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5276)
All Articles published online
|
Publishing Process of This Article
|
Aug 15, 2023 (publication date) through Apr 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Juneja D, Nasa P, Jain R, Singh O. Sodium-glucose Cotransporter-2 Inhibitors induced euglycemic diabetic ketoacidosis: A meta summary of case reports. World J Diabetes 2023; 14(8): 1314-1322 [PMID: 37664476 DOI: 10.4239/wjd.v14.i8.1314] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v14/i8/1314.htm |
| Number | Citing Articles |
| 1 |
Alessandro Rossi, Chiara Simeoli, Rosario Pivonello, Mariacarolina Salerno, Carmen Rosano, Barbara Brunetti, Pietro Strisciuglio, Annamaria Colao, Giancarlo Parenti, Daniela Melis, Terry G.J. Derks. Endocrine involvement in hepatic glycogen storage diseases: pathophysiology and implications for care. Reviews in Endocrine and Metabolic Disorders 2024; 25(4): 707 doi: 10.1007/s11154-024-09880-2
|
| 2 |
Swapnil Khare, Mihail Zilbermint, Rajesh Garg, Viral N. Shah. Navigating the New Frontiers of Hyperglycemic Crisis Management: Unveiling the Latest American Diabetes Association Consensus Report. Endocrine Practice 2024; 30(9): 895 doi: 10.1016/j.eprac.2024.06.011
|
| 3 |
Lulu Chu, Zhenhua Xi, Runzhi Ma, Weiliang Shi, Guoshen Yu. Euglycemic diabetic ketoacidosis associated metabolic encephalopathy caused by dapagliflozin: a rare case report. BMC Neurology 2025; 25(1) doi: 10.1186/s12883-025-04027-5
|
| 4 |
Caroline G. P. Roberts, Shaminie J. Athinarayanan, Robert E. Ratner, Guillermo E. Umpierrez. Illnesses associated with ketosis including diabetic ketoacidosis during very low carbohydrate and ketogenic diets. Diabetes, Obesity and Metabolism 2025; 27(5): 2531 doi: 10.1111/dom.16252
|
| 5 |
Dimitra Stathi, Ketan K. Dhatariya, Omar G. Mustafa. Management of diabetes‐related hyperglycaemic emergencies in advanced chronic kidney disease: Review of the literature and recommendations. Diabetic Medicine 2025; 42(2) doi: 10.1111/dme.15405
|
| 6 |
Andreas Holstein, Jonas A. Linck, Johann Christoph Blaue, Rainer Högel, David J. F. Holstein. Successful renal replacement therapy of extreme ertugliflozin and alcohol induced euglycaemic ketoacidosis. Acta Diabetologica 2024; 62(3): 433 doi: 10.1007/s00592-024-02417-8
|
| 7 |
Andrijana Koceva, Nika Aleksandra Kravos Tramšek. From Sweet to Sour: SGLT-2-Inhibitor-Induced Euglycemic Diabetic Ketoacidosis. Journal of Personalized Medicine 2024; 14(7): 665 doi: 10.3390/jpm14070665
|
| 8 |
Rohini Garg, Nikhil Sood, Ojas Bansal, Abhinav Hoskote. Euglycemic Ketoacidosis Associated with SGLT-2 Inhibitors in Non-diabetic Patients—A Narrative Review. Journal of General Internal Medicine 2025; 40(2): 437 doi: 10.1007/s11606-024-09073-2
|
| 9 |
Selin Genc, Bahri Evren, Onur Selcuk Yigit, Ibrahim Sahin, Ramazan Dayanan, Aleksandra Klisic, Ayse Erturk, Filiz Mercantepe. Evolving Clinical Features of Diabetic Ketoacidosis: The Impact of SGLT2 Inhibitors. Pharmaceuticals 2024; 17(11): 1553 doi: 10.3390/ph17111553
|
| 10 |
Afif Nakhleh, Areen Othman, Amin Masri, Moshe Zloczower, Sagit Zolotov, Naim Shehadeh. Clinical Outcomes of Diabetic Ketoacidosis in Type 2 Diabetes Patients with and without SGLT2 Inhibitor Treatment: A Retrospective Study. Biomedicines 2023; 11(10): 2689 doi: 10.3390/biomedicines11102689
|
| 11 |
Paul A. Stewart, Claire C. Nestor, Cillian Clancy, Michael G. Irwin. The peri‐operative implications of sodium‐glucose co‐transporter 2 inhibitors: a narrative review. Anaesthesia 2025; 80(1): 85 doi: 10.1111/anae.16461
|